Jibo Han
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
Papers in
-
- Inflammasome and immune disorders 12
- Ubiquitin and proteasome pathways 8
- Plant-derived Lignans Synthesis and Bioactivity 5
- Genomics, phytochemicals, and oxidative stress 4
-
- Cardiac Fibrosis and Remodeling 3
- Cardiovascular Function and Risk Factors 3
- Co-authors
- Weijian Huang (17 shared papers)Bozhi Ye (25 shared papers)Guang Liang (15 shared papers)Shanshan Dai (8 shared papers)Jianjiang Xu (13 shared papers)Zhouqing Huang (8 shared papers)Shuang Lin (5 shared papers)Xueli Cai (6 shared papers)
In The Last Decade
Jibo Han
60 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 88
- Nephrology 128
- Cardiology and Cardiovascular Medicine 299
- Immunology 253
- Molecular Biology 758
- Complementary and alternative medicine 66
Countries citing papers authored by Jibo Han
This map shows the geographic impact of Jibo Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jibo Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jibo Han more than expected).
Fields of papers citing papers by Jibo Han
This network shows the impact of papers produced by Jibo Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jibo Han. The network helps show where Jibo Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Jibo Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 158 | |
| 2 | 2020 | 118 | |
| 3 | 2016 | 100 | |
| 4 | 2018 | 86 | |
| 5 | 2023 | 85 | |
| 6 | 2017 | 84 | |
| 7 | 2022 | 57 | |
| 8 | 2022 | 56 | |
| 9 | 2019 | 54 | |
| 10 | 2018 | 53 | |
| 11 | 2022 | 46 | |
| 12 | 2024 | 43 | |
| 13 | 2017 | 36 | |
| 14 | 2015 | 35 | |
| 15 | 2023 | 34 | |
| 16 | 2022 | 33 | |
| 17 | 2022 | 31 | |
| 18 | 2021 | 31 | |
| 19 | 2021 | 26 | |
| 20 | 2018 | 24 |
About Jibo Han
Jibo Han is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Immunology, Nephrology and Pulmonary and Respiratory Medicine, having authored 62 papers that have together received 1.6k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (12 papers), Ubiquitin and proteasome pathways (8 papers), Plant-derived Lignans Synthesis and Bioactivity (5 papers), interferon and immune responses (4 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Cardiac Fibrosis and Remodeling (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Cardiovascular Function and Risk Factors (3 papers). The work is most often cited by research in Nephrology (128 citations), Cardiology and Cardiovascular Medicine (299 citations), Immunology (253 citations), Molecular Biology (758 citations) and Complementary and alternative medicine (66 citations). Jibo Han has collaborated with scholars based in China, Canada and Russia. Frequent co-authors include Weijian Huang, Bozhi Ye, Guang Liang, Shanshan Dai, Jianjiang Xu, Zhouqing Huang, Shuang Lin, Xueli Cai, Chunpeng Zou and Gaojun Wu. Their work appears in journals such as European Archives of Oto-Rhino-Laryngology, International Immunopharmacology, Drug Design Development and Therapy, Phytomedicine and Clinical and Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.